{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:46:40Z","timestamp":1787312800784,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Govt. of India, New Delhi","doi-asserted-by":"publisher","award":["SR\/WOS-A\/LS-71\/2010"],"award-info":[{"award-number":["SR\/WOS-A\/LS-71\/2010"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.yrtph.2017.10.023","type":"journal-article","created":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T11:48:29Z","timestamp":1509968909000},"page":"179-189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Safety against nephrotoxicity in paclitaxel treatment: Oral nanocarrier as an effective tool in preclinical evaluation with marked in vivo antitumor activity"],"prefix":"10.1016","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8723-981X","authenticated-orcid":false,"given":"Hira","family":"Choudhury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bapi","family":"Gorain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh Kumar","family":"Tekade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanmoy","family":"Karmakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapan Kumar","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2017.10.023_bib1","first-page":"3418","volume":"23","author":"Arakawa","year":"2008","journal-title":"Activation signal transducer activator Transcr. 3 Correl. Cell Prolif. Ren. Inj. Hum. glomerulonephritis"},{"key":"10.1016\/j.yrtph.2017.10.023_bib2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1208\/s12249-008-9178-x","article-title":"Nanoemulsion components screening and selection: a technical note","volume":"10","author":"Azeem","year":"2009","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.yrtph.2017.10.023_bib3","first-page":"5397","article-title":"Modification of paclitaxel-loaded solid lipid nanoparticles with 2-hydroxypropyl-\u03b2-cyclodextrin enhances absorption and reduces nephrotoxicity associated with intravenous injection","volume":"10","author":"Baek","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.yrtph.2017.10.023_bib4","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1002\/jps.24354","article-title":"Controlled release, intestinal transport, and oral bioavailablity of paclitaxel can be considerably increased using suitably tailored pegylated poly(anhydride) nanoparticles","volume":"104","author":"Calleja","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.yrtph.2017.10.023_bib5","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1039\/C5TX00049A","article-title":"Toxicological assessment of PEG functionalized f-block rare earth phosphate nanorods","volume":"4","author":"Chall","year":"2015","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.yrtph.2017.10.023_bib6","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00280-015-2833-5","article-title":"Albumin-bound nanoparticle (nab) paclitaxel exhibits enhanced paclitaxel tissue distribution and tumor penetration","volume":"76","author":"Chen","year":"2015","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.yrtph.2017.10.023_bib7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/0005-2736(91)90333-4","article-title":"Mechanism of hemolysis of red blood cell mediated by ethanol","volume":"1062","author":"Chi","year":"1991","journal-title":"Biochim. Biophys. Acta - Biomembr."},{"key":"10.1016\/j.yrtph.2017.10.023_bib8","series-title":"Application of Nanotechnology in Drug Delivery","article-title":"Nanoemulsions \u2014 advances in formulation, characterization and applications in drug delivery","author":"Chime","year":"2014"},{"key":"10.1016\/j.yrtph.2017.10.023_bib9","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.2174\/1381612822666161201143600","article-title":"Pharmacokinetic and pharmacodynamic features of nanoemulsion following oral, intravenous, topical and nasal route","volume":"23","author":"Choudhury","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.yrtph.2017.10.023_bib10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijpharm.2013.10.055","article-title":"Improvement of cellular uptake, in vitro antitumor activity and sustained release profile with increased bioavailability from a nanoemulsion platform","volume":"460","author":"Choudhury","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.yrtph.2017.10.023_bib11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/chromsci\/bms206","article-title":"Development and validation of RP-HPLC method: scope of application in the determination of oil solubility of paclitaxel","volume":"52","author":"Choudhury","year":"2014","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.yrtph.2017.10.023_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2017.03.042","article-title":"Recent update on nanoemulgel as topical drug delivery system","author":"Choudhury","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.yrtph.2017.10.023_bib13","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ijpharm.2017.07.018","article-title":"Recent advances in TPGS-based nanoparticles of docetaxel for improved chemotherapy","volume":"529","author":"Choudhury","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.yrtph.2017.10.023_bib14","first-page":"3025","article-title":"Development of tumor-infiltrating lymphocytes in breast cancer after neoadjuvant paclitaxel chemotherapy","volume":"7","author":"Demaria","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yrtph.2017.10.023_bib15","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0959-8049(01)00171-X","article-title":"Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation","volume":"37","author":"Gelderblom","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.yrtph.2017.10.023_bib16","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1007\/s00520-015-3020-2","article-title":"Chemotherapy-induced gut toxicity and pain: involvement of TLRs","volume":"24","author":"Gibson","year":"2016","journal-title":"Support. Care Canc."},{"key":"10.1016\/j.yrtph.2017.10.023_bib17","doi-asserted-by":"crossref","DOI":"10.1039\/c3ra41452c","article-title":"A novel approach for nanoemulsion components screening and nanoemulsion assay of olmesartan medoxomil through a developed and validated HPLC method","volume":"3","author":"Gorain","year":"2013","journal-title":"RSC Adv."},{"key":"10.1016\/j.yrtph.2017.10.023_bib18","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.yrtph.2016.10.020","article-title":"Comparative biodistribution and safety profiling of olmesartan medoxomil oil-in-water oral nanoemulsion","volume":"82","author":"Gorain","year":"2016","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2017.10.023_bib19","series-title":"Histopathology of Preclinical Toxicity Studies: Interpretation and Relevance in Drug Safety Studies","author":"Greaves","year":"2012"},{"key":"10.1016\/j.yrtph.2017.10.023_bib20","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.3923\/pjbs.2007.3815.3821","article-title":"Phytochemical and toxicological studies of aqueous leaves extracts of Erythrophleum africanum","volume":"10","author":"Hassan","year":"2007","journal-title":"Pak. J. Biol. Sci. PJBS"},{"key":"10.1016\/j.yrtph.2017.10.023_bib21","article-title":"Effect of honey and eugenol on ehrlich ascites and solid carcinoma","volume":"2010","author":"Jaganathan","year":"2010","journal-title":"Biomed. Res."},{"key":"10.1016\/j.yrtph.2017.10.023_bib22","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/BF02341965","article-title":"The relevance of clinical pathology to toxicology studies","volume":"3","author":"James","year":"1993","journal-title":"Comp. Haematol. Int."},{"key":"10.1016\/j.yrtph.2017.10.023_bib23","first-page":"3141","article-title":"Preparation and characteristics of lipid nanoemulsion formulations loaded with doxorubicin","volume":"8","author":"Jiang","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.yrtph.2017.10.023_bib24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejca.2004.09.026","article-title":"Chemotherapy-induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatment","volume":"41","author":"Jordan","year":"2005","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.yrtph.2017.10.023_bib25","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.nano.2010.12.002","article-title":"A nanoemulsion formulation of dacarbazine reduces tumor size in a xenograft mouse epidermoid carcinoma model compared to dacarbazine suspension","volume":"7","author":"Kakumanu","year":"2011","journal-title":"Nanomedicine Nanotechnol. Biol. Med."},{"key":"10.1016\/j.yrtph.2017.10.023_bib26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0168-3659(02)00049-4","article-title":"Microemulsion formulation for enhanced absorption of poorly soluble drugs: I. Prescription design","volume":"81","author":"Kawakami","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.yrtph.2017.10.023_bib27","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1042\/cs0560273","article-title":"Synthetic detergents in bile-salt-deficient steatorrhoea","volume":"56","author":"King","year":"1979","journal-title":"Clin. Sci."},{"key":"10.1016\/j.yrtph.2017.10.023_bib28","first-page":"272","article-title":"Nanoemulsion based targeting in cancer therapeutics","volume":"5","author":"Kumar","year":"2015","journal-title":"Med. Chem."},{"key":"10.1016\/j.yrtph.2017.10.023_bib29","first-page":"4509","article-title":"Preferential sites of growth of human tumors in nude mice following subcutaneous transplantation","volume":"40","author":"Kyriazis","year":"1980","journal-title":"Cancer Res."},{"key":"10.1016\/j.yrtph.2017.10.023_bib30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/ckj\/sft135","article-title":"Nephrotoxicity of recent anti-cancer agents","volume":"7","author":"Lameire","year":"2014","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.yrtph.2017.10.023_bib31","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s11095-016-1908-2","article-title":"Synthesis and in vitro evaluation of polyethylene glycol-paclitaxel conjugates for lung cancer therapy","volume":"33","author":"Luo","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.yrtph.2017.10.023_bib32","doi-asserted-by":"crossref","first-page":"e115103","DOI":"10.1371\/journal.pone.0115103","article-title":"The value of tumor infiltrating lymphocytes (TILs) for predicting response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis","volume":"9","author":"Mao","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.yrtph.2017.10.023_bib33","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1080\/01926230701595292","article-title":"Evaluation of organ weights for rodent and non-rodent toxicity studies: a review of regulatory guidelines and a survey of current practices","volume":"35","author":"Michael","year":"2007","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.yrtph.2017.10.023_bib34","series-title":"New Drugs, Concepts and Results in Cancer Chemotherapy","author":"Muggia","year":"1991"},{"key":"10.1016\/j.yrtph.2017.10.023_bib35","series-title":"Test No. 407: Repeated Dose 28-day Oral Toxicity Study in Rodents, OECD Guidelines for the Testing of Chemicals, Section 4","author":"OECD","year":"2008"},{"key":"10.1016\/j.yrtph.2017.10.023_bib36","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s10637-010-9421-7","article-title":"Paclitaxel in self-micro emulsifying formulations: oral bioavailability study in mice","volume":"29","author":"Oostendorp","year":"2011","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.yrtph.2017.10.023_bib37","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1248\/jhs.49.444","article-title":"Sub-chronic toxicity studies of the aqueous extract of boerhavia diffusa leaves","volume":"49","author":"Orisakwe","year":"2003","journal-title":"J. Heal. Sci."},{"key":"10.1016\/j.yrtph.2017.10.023_bib38","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1634\/theoncologist.3-6-373","article-title":"Paclitaxel in breast cancer","volume":"3","author":"Perez","year":"1998","journal-title":"Oncologist"},{"key":"10.1016\/j.yrtph.2017.10.023_bib39","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.sjbs.2010.02.003","article-title":"Acute Taxol nephrotoxicity: histological and ultrastructural studies of mice kidney parenchyma","volume":"17","author":"Rabah","year":"2010","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.yrtph.2017.10.023_bib40","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jep.2008.05.009","article-title":"Acute and sub-chronic toxicity of an aqueous extract of the leaves of Herniaria glabra in rodents","volume":"118","author":"Rhiouani","year":"2008","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.yrtph.2017.10.023_bib41","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ejps.2005.08.001","article-title":"Studies on the formation of O\/W nano-emulsions, by low-energy emulsification methods, suitable for pharmaceutical applications","volume":"26","author":"Sadurn\u00ed","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.yrtph.2017.10.023_bib42","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1517\/17425247.2015.1060219","article-title":"Novel dietary lipid-based self-nanoemulsifying drug delivery systems of paclitaxel with p-gp inhibitor: implications on cytotoxicity and biopharmaceutical performance","volume":"12","author":"Sandhu","year":"2015","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.yrtph.2017.10.023_bib43","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1073\/pnas.94.5.2031","article-title":"Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine","volume":"94","author":"Sparreboom","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yrtph.2017.10.023_bib44","doi-asserted-by":"crossref","DOI":"10.1007\/s12098-007-0118-7","article-title":"Symposium: newer diagnostic tests liver function tests and their interpretation","volume":"74","author":"Thapa","year":"2007","journal-title":"Indian J. Pediatr."},{"key":"10.1016\/j.yrtph.2017.10.023_bib45","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0925-4439(00)00086-7","article-title":"Does ethanol metabolism affect erythrocyte hemolysis?","volume":"1535","author":"Tyulina","year":"2000","journal-title":"Biochim. Biophys. Acta - Mol. Basis Dis."},{"key":"10.1016\/j.yrtph.2017.10.023_bib46","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/sj.bjc.6690696","article-title":"Cremophor EL causes (pseudo-) non-linear pharmacokinetics of paclitaxel in patients","volume":"81","author":"van Tellingen","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.yrtph.2017.10.023_bib47","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1350-9462(01)00017-9","article-title":"Microemulsions as ocular drug delivery systems: recent developments and future challenges","volume":"21","author":"Vandamme","year":"2002","journal-title":"Prog. Retin. Eye Res."},{"issue":"10","key":"10.1016\/j.yrtph.2017.10.023_bib48","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2147\/IJN.S79991","article-title":"Acute and subchronic toxicity analysis of surface modified paclitaxel attached hydroxyapatite and titanium dioxide nanoparticles","volume":"1","author":"Venkatasubbu","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.yrtph.2017.10.023_bib49","article-title":"Therapeutic targeting of erbB3 with MM-121\/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancer","volume":"15","author":"Wang","year":"2013","journal-title":"Breast Cancer"},{"key":"10.1016\/j.yrtph.2017.10.023_bib50","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.ejso.2015.04.018","article-title":"Adjuvant intensity-modulated radiotherapy (IMRT) with concurrent paclitaxel and cisplatin in cervical cancer patients with high risk factors: a phase II trial","volume":"41","author":"Wang","year":"2015","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.yrtph.2017.10.023_bib51","doi-asserted-by":"crossref","first-page":"6006","DOI":"10.1016\/j.biomaterials.2009.07.015","article-title":"A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer","volume":"30","author":"Xiao","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.yrtph.2017.10.023_bib52","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.3390\/molecules20034337","article-title":"Bioavailability enhancement of paclitaxel via a novel oral drug delivery system: paclitaxel-loaded glycyrrhizic acid micelles","volume":"20","author":"Yang","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.yrtph.2017.10.023_bib53","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.2147\/DDDT.S81390","article-title":"Paclitaxel attenuates renal interstitial fibroblast activation and interstitial fibrosis by inhibiting STAT3 signaling","volume":"9","author":"Zhang","year":"2015","journal-title":"Drug Des. devel. Ther."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230017303380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230017303380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T01:31:08Z","timestamp":1603243868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230017303380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":53,"alternative-id":["S0273230017303380"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2017.10.023","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety against nephrotoxicity in paclitaxel treatment: Oral nanocarrier as an effective tool in preclinical evaluation with marked in vivo antitumor activity","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2017.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}